🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
GeneReach Biotechnology Corp. (TPEX:4171)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
12.20
-1.10 (-8.27%)
Nov 20, 2026, 1:21 PM CST

GeneReach Biotechnology Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
119.1155.07110.27216.77748.61663.43
Short-Term Investments
236.43114181.01285.95--
Trading Asset Securities
22.2320.69122.7---
Cash & Short-Term Investments
377.77289.76413.98502.72748.61663.43
Cash Growth
46.79%-30.01%-17.65%-32.85%12.84%111.50%
Accounts Receivable
25.0539.3743.0521.4755.86195.75
Other Receivables
1.772.163.371.680.40.72
Receivables
26.8241.5346.4223.1456.26196.47
Inventory
43.9532.5637.5267.37235.81268.3
Prepaid Expenses
3.581.883.245.888.3634.68
Other Current Assets
4.29118.4393.5133.0121.0317.66
Total Current Assets
456.4484.16594.67632.141,0701,181
Property, Plant & Equipment
254.64284.73359.65433.83436.93397.11
Long-Term Investments
3.24----3.24
Other Intangible Assets
13.4215.4312.412.359.4910.03
Long-Term Deferred Tax Assets
82.1781.7883.2177.6535.2624
Other Long-Term Assets
15.1814.9516.5620.1870.1569.51
Total Assets
825.05881.051,0661,1761,6221,684

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
7.17.197.748.8613.3531.68
Short-Term Debt
1261361711044949
Current Portion of Long-Term Debt
---35.62204.427.5
Current Portion of Leases
11.511.411.6411.3812.648.54
Current Income Taxes Payable
--73.5923.0874.45
Current Unearned Revenue
3.813.342.934.967.819.43
Other Current Liabilities
34.4143.239.2137.574.887.62
Total Current Liabilities
182.82201.13239.53205.9385.09278.21
Long-Term Debt
----15217.39
Long-Term Leases
63.2871.784.5997.74108.8987.35
Long-Term Unearned Revenue
0.529.5310.578.788.958.82
Pension & Post-Retirement Benefits
-----1.73
Long-Term Deferred Tax Liabilities
2.051.996.291.261.281.2
Other Long-Term Liabilities
9.64-0.020.020.021.64
Total Liabilities
258.31284.34341313.71519.23596.35

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
580.58580.58574.58574.58459.66417.87
Additional Paid-In Capital
150.54150.54144.9144.9144.9144.9
Retained Earnings
-142.22-117.32-3.29114.74464.44491.74
Treasury Stock
-25.73-17.31----
Comprehensive Income & Other
-4.59-9.760.79-2.15-1.33-4.7
Total Common Equity
558.57586.73716.98832.061,0681,050
Minority Interest
8.169.998.5130.3735.0138.26
Shareholders' Equity
566.74596.72725.49862.441,1031,088
Total Liabilities & Equity
825.05881.051,0661,1761,6221,684

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
200.78219.1267.23248.74389.95369.78
Net Cash (Debt)
176.9970.67146.75253.98358.66293.65
Net Cash Growth
396.42%-51.84%-42.22%-29.19%22.14%133.48%
Net Cash Per Share
3.131.242.554.426.055.01
Filing Date Shares Outstanding
55.8657.357.4657.4657.4657.46
Total Common Shares Outstanding
55.8657.357.4657.4657.4657.46
Working Capital
273.59283.03355.14426.24684.99902.32
Book Value Per Share
10.0010.2412.4814.4818.5818.27
Tangible Book Value
545.16571.29704.59819.721,0581,040
Tangible Book Value Per Share
9.769.9712.2614.2718.4218.10
Buildings
-296.08293.85292.04267.33266.03
Machinery
-306.55332.71309.58273.19231.16
Construction In Progress
-0.26--20.95-